Chemoinformaics analysis of 1,5,6-TRIHYDROXY-3,7-DIMETHOXYXANTHEN-9-ONE
| Molecular Weight | 304.254 | nRot | 2 |
| Heavy Atom Molecular Weight | 292.158 | nRig | 17 |
| Exact Molecular Weight | 304.058 | nRing | 3 |
| Solubility: LogS | -3.541 | nHRing | 1 |
| Solubility: LogP | 2.34 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 14 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 16 |
| nHA | 7 | APOL | 38.6655 |
| nHD | 3 | BPOL | 18.1145 |
| QED | 0.491 |
| Synth | 2.499 |
| Natural Product Likeliness | 1.388 |
| NR-PPAR-gamma | 0.969 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.219 |
| Pgp-sub | 0.015 |
| HIA | 0.124 |
| CACO-2 | -5.122 |
| MDCK | 0.0000126 |
| BBB | 0.007 |
| PPB | 0.871645 |
| VDSS | 0.915 |
| FU | 0.195773 |
| CYP1A2-inh | 0.913 |
| CYP1A2-sub | 0.962 |
| CYP2c19-inh | 0.043 |
| CYP2c19-sub | 0.105 |
| CYP2c9-inh | 0.544 |
| CYP2c9-sub | 0.807 |
| CYP2d6-inh | 0.238 |
| CYP2d6-sub | 0.359 |
| CYP3a4-inh | 0.16 |
| CYP3a4-sub | 0.111 |
| CL | 6.696 |
| T12 | 0.852 |
| hERG | 0.014 |
| Ames | 0.634 |
| ROA | 0.171 |
| SkinSen | 0.884 |
| Carcinogencity | 0.031 |
| EI | 0.882 |
| Respiratory | 0.274 |
| NR-Aromatase | 0.835 |
| Antiviral | Yes |
| Prediction | 0.684729 |